Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EUG | Ann: EUG NTA 02-09-2025 $4.11338 | 07:58 | 0 | 21 | |||
|
|||||||
EUG | Ann: EUG NTA 01-09-2025 $4.10293 | 02/09/25 | 0 | 32 | |||
|
|||||||
EUG | Ann: EUG NTA 29-08-2025 $4.13759 | 01/09/25 | 0 | 21 | |||
|
|||||||
EUG | Ann: EUG NTA 28-08-2025 $4.14696 | 29/08/25 | 0 | 34 | |||
|
|||||||
EUG | Ann: EUG NTA 27-08-2025 $4.15027 | 28/08/25 | 0 | 27 | |||
|
|||||||
EUG | Ann: EUG NTA 26-08-2025 $4.18296 | 27/08/25 | 0 | 36 | |||
|
|||||||
EUG | Ann: EUG NTA 25-08-2025 $4.22208 | 26/08/25 | 0 | 56 | |||
|
|||||||
EUG | Ann: EUG NTA 22-08-2025 $4.19882 | 25/08/25 | 0 | 38 | |||
|
See All Discussions